APP and early-onset autosomal dominant Alzheimer disease: Just as measuring Amyloid Precursor Protein (APP) levels in platelets can serve as a diagnostic tool for assessing Alzheimer’s disease severity [178], it is reasonable to consider protein levels as biomarkers for future complications.